Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.80
-1.30 (-2.59%)
Sep 4, 2025, 1:56 PM CST
-2.59%
Market Cap3.57B
Revenue (ttm)n/a
Net Income (ttm)-141.91M
Shares Out71.31M
EPS (ttm)-1.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,847
Average Volume52,746
Open50.10
Previous Close50.10
Day's Range48.35 - 50.10
52-Week Range34.30 - 68.50
Beta-0.06
RSI48.81
Earnings DateAug 11, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630 drug, for which is in Phase II clinical trial. It is also developing SNP-810 is in phase II clinical trial for use in Pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for acetamino... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.